August 11, 2020
Fulcrum Therapeutics
Fulcrum Therapeutics Announces Interim Analysis Data from its ReDUX4 Trial in Facioscapulohumeral Muscular Dystrophy (FSHD)
August 11, 2020
bluebird bio
bluebird bio Appoints Denice Torres to Board of Directors
August 11, 2020
MyoKardia
MyoKardia and LianBio Form Strategic Partnership to Develop and Commercialize Mavacamten Together in Greater China
August 11, 2020
Fulcrum Therapeutics
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
August 11, 2020
Pliant Therapeutics
Pliant Therapeutics Provides Corporate Update and Announces Second-Quarter 2020 Financial Results